MIC
NVO

Means Investment Company’s Novo Nordisk NVO Stock Holding History

Means Investment Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,387
Closed -$372K – 195
2025
Q2 		$372K Sell
5,387
-10,629
-66% -$723K 0.04% 144
2025
Q1 		$1.11M Sell
16,016
-34,124
-68% -$2.82M 0.12% 84
2024
Q4 		$4.31M Sell
50,140
-1,837
-4% -$199K 0.45% 40
2024
Q3 		$6.19M Buy
51,977
+2,907
+6% +$388K 0.69% 28
2024
Q2 		$7M Buy
49,070
+9,488
+24% +$1.26M 0.84% 24
2024
Q1 		$5.08M Buy
39,582
+15,254
+63% +$1.82M 0.66% 29
2023
Q4 		$2.52M Buy
24,328
+10,316
+74% +$1.02M 0.36% 47
2023
Q3 		$1.27M Buy
14,012
+10,644
+316% +$938K 0.21% 79
2023
Q2 		$273K Buy
+3,368
New +$275K 0.04% 168

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Means Investment Company's NVO Position: Q3 2025 in Review

Means Investment Company sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,387 shares — an estimated $372K sold.

Means Investment Company first reported a position in NVO in Q2 2023 and held it in 9 quarters. The position peaked at $7M in Q2 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Means Investment Company reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Means Investment Company sold 5,387 Novo Nordisk shares in Q3 2025, an estimated $372K.
  • Means Investment Company first reported a position in Novo Nordisk in Q2 2023 and held it in 9 quarters.
  • Means Investment Company's Novo Nordisk position peaked at $7M in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Means Investment Company's 13F filing for Q3 2025, filed 6 Nov 2025.